Partnership integrates Scipher’s PrismRA to deliver insights into therapy response segmentation Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights,
Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer treatment decisions Artera, the developer of multimodal artificial
HealthTrackRx, the nation’s premier infectious disease laboratory, released the findings of a recent survey to better understand how next-morning PCR results impact patient care and
Six months after implementing BioVigil‘s electronic hand hygiene solution, an automated way to monitor and measure staff hand hygiene behavior, Griffin Hospital has strengthened its
RareMed Solutions is proud to announce that the company continues to lead the nation in patient satisfaction, achieving a highest-ever-recorded Net Promoter Score of 100
Innovative foam support surface technology helps enhance patient comfort and reduce risk of surface contamination in the emergency and perioperative departments Agiliti, a leading manufacturer
RxWellness Spine & Health, the Mid-Atlantic’s leading natural-first healthcare clinic network and platform for integrative care, announced the strategic partnership and acquisition of AllCare Chiropractic & AllCare
In further commitment to increasing health care access to rural and underserved communities, Seven Corners Healthcare has announced a strategic investment in the innovative startup
Results from the Phase 3 AMPLITUDE study show the potential of AKEEGA (niraparib and abiraterone acetate dual-action tablet) to delay cancer progression and worsening of symptoms
Brina Medical LLC proudly launches the CMAT Advantage — a revolutionary next-generation point-of-care diagnostic device engineered to empower hospitals and healthcare providers to outpace the relentless rise
Vepdegestrant was generally well tolerated, with few discontinuations and low rates of gastrointestinal-related adverse events Arvinas, Inc. announced detailed results from the Phase 3 VERITAC-2
The initiative will apply its massive, multimodal dataset to build models that aim to improve diagnostic, prognostic, and predictive modeling Tempus AI, a technology company
